arBtrage CAPITALIZING MARKETS checking… Sign in

Harrow, Inc.

HROW Health Care Biotechnology: Pharmaceutical Preparations
$33.19
▼ -4.3% Today
as of Jun 7, 07:17 ET
Last 30 days -18.01% Apr 28 → Jun 05
$28.08 $31.52 $34.97 $38.41 $41.85 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$34.59
High
$34.90
Low
$33.10
Volume
$637,010
Avg Vol
$669,591
Mkt Cap
$1.3B
P/E (TTM)
Beta
52w High
$54.85
52w Low
$27.76
Div Yield
Shares Out
$37M

Overview

52-week range
$28
$55
20% of range
Avg surprise (last 2)
-1,023%
Avg reaction (last 2)
-2.3%
0% positive
Latest IV / EM
95%
EM ±13.1% · $33 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.63$-0.44$-0.25$-0.06$0.13 Actual $-0.14Actual $-0.13Actual $-0.38Actual $-0.18Actual $-0.12Actual $-0.38Est $0.02Actual $0.13Actual $0.03Actual $-0.63Est $-0.43 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-28M$-19M$-11M$-3M$5M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $-0.63 $-0.43 -46.5% -65.8% -0.5% earnings
Tue Sep 30, 2025Sep 2025 $0.03 financials
Mon Jun 30, 2025Jun 2025 $0.13 financials
Thu May 8, 2025Mar/2025 $-0.38 $0.02 -2,000% -4.1% earnings
Mon Sep 30, 2024Sep 2024 $-0.12 financials
Sun Jun 30, 2024Jun 2024 $-0.18 financials
Sun Mar 31, 2024Mar 2024 $-0.38 financials
Sat Sep 30, 2023Sep 2023 $-0.13 financials
Fri Jun 30, 2023Jun 2023 $-0.14 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$17M$18M$16M$16M$12M$13M
Gross profit$27M$54M$48M$32M$37M$36M
Operating income$-22M$15M$11M$-11M$1M$2M
Net income$-28M$1M$5M$-18M$-4M$-6M
EPS (diluted)$-0.74$0.03$0.13$-0.50$-0.12$-0.18

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$95M$73M$74M$53M$67M$47M$73M$71M
Inventory$16M$14M$13M$12M$11M$11M$10M$9M
Total current assets$226M$212M$178M$155M$170M$190M$147M$139M
Total assets$420M$399M$363M$345M$364M$389M$352M$307M
Long-term debt$300M$347M$251M$257M$231M$236M
Total liabilities$391M$347M$316M$296M$308M$320M$294M$248M
Total equity$29M$52M$47M$50M$56M$70M$58M$59M

Implied volatility — last 90 days

89%92%94%97%99% Jun 07 — IV 95% · EM ±13.1%

Sector peers